NCT04045145 · Interventional trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 (Crinecerfont) in Pediatric Participants With Congenital Adrenal Hyperplasia
Overall registry status Completed
Phase 2
Conditions CAH - Congenital Adrenal Hyperplasia
Delaware Valley sites
- Neurocrine Clinical Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory